Advertisement

AIDS and Behavior

, Volume 21, Issue 12, pp 3299–3311 | Cite as

Perceived Barriers and Facilitators to Integrating HIV Prevention and Treatment with Cross-Sex Hormone Therapy for Transgender Women in Lima, Peru

  • Sari L. Reisner
  • Amaya G. Perez-Brumer
  • Sarah A. McLean
  • Javier R. Lama
  • Alfonso Silva-Santisteban
  • Leyla Huerta
  • Jorge Sanchez
  • Jesse L. Clark
  • Matthew J. Mimiaga
  • Kenneth H. Mayer
Original Paper

Abstract

Transgender women (TW) represent a vulnerable population at increased risk for HIV infection in Peru. A mixed-methods study with 48 TW and 19 healthcare professionals was conducted between January and February 2015 to explore barriers and facilitators to implementing a model of care that integrates HIV services with gender-affirmative medical care (i.e., hormone therapy) in Lima, Peru. Perceived acceptability of the integrated care model was high among TW and healthcare professionals alike. Barriers included stigma, lack of provider training or Peruvian guidelines regarding optimal TW care, and service delivery obstacles (e.g., legal documents, spatial placement of clinics, hours of operation). The hiring of TW staff was identified as a key facilitator for engagement in health care. Working in partnership with local TW and healthcare provider organizations is critical to overcoming existing barriers to successful implementation of an integrated HIV services and gender-affirmative medical care model for this key population in Peru.

Keywords

Transgender women HIV infection Models of care 

Resumen

Las mujeres transgénero (MT) representan una población vulnerable con mayor riesgo de infección por el VIH en Perú. Entre enero y febrero de 2015 se realizó un estudio de métodos mixtos con 48 MT y 19 profesionales de la salud para explorar las barreras y los facilitadores para implementar un modelo de atención que integra servicios de VIH con atención médica para la afirmación de género. La percepción de aceptación del modelo integrado de atención fue alta entre los MT y los profesionales de la salud por igual. Las barreras incluyen el estigma, la falta de capacitación del proveedor o las guías peruanas sobre el cuidado óptimo de MT y los obstáculos en la prestación de servicios (por ejemplo, documentos legales, colocación espacial de las clínicas, horas de operación). La contratación del personal MT fue identificada como un facilitador clave para la participación en el cuidado de la salud. Trabajar en asociación con MT locales y organizaciones proveedoras de atención médica es fundamental para superar las barreras existentes para la implementación exitosa de un servicio integrado de VIH y un modelo de atención médica de afirmación de género para esta población clave en Perú.

Notes

Acknowledgements

The authors would like to acknowledge Robert de la Grecca, Hugo Sanchez, Patricia Segura, and Milan Satcher for their contributions to this project, and especially thank the transgender women who shared their experiences and insights with us.

Funding

This study was funded by amfAR, The Foundation for AIDS Research, Grant No. 109071-57-HGMM (PI: Dr. Javier R. Lama). APB is supported by a National Institute of Child Health & Human Development T32 Grant (T32HD049339; PI: Nathanson).

Compliance with Ethical Standards

Conflicts of interest

All authors declare that they have no conflicts of interest.

Research involving human participants

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Poteat T, et al. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S210–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Baral SD, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.CrossRefPubMedGoogle Scholar
  3. 3.
    Silva-Santisteban A, et al. Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: results from a sero-epidemiologic study using respondent driven sampling. AIDS Behav. 2012;16(4):872–81.CrossRefPubMedGoogle Scholar
  4. 4.
    Clark JL, et al. Sampling methodologies for epidemiologic surveillance of men who have sex with men and transgender women in Latin America: an empiric comparison of convenience sampling, time space sampling, and respondent driven sampling. AIDS Behav. 2014;18(12):2338–48.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Reisner S, et al. Global health burden and needs of transgender populations: a review. The Lancet. 2016;388(10042):412–36.CrossRefGoogle Scholar
  6. 6.
    Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9(2):168–73.CrossRefPubMedGoogle Scholar
  7. 7.
    De Santis JP. HIV infection risk factors among male-to-female transgender persons: a review of the literature. J Assoc Nurses AIDS Care. 2009;20(5):362–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Reisner SL, Perkovich B, Mimiaga MJ. A mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men. AIDS Patient Care STDS. 2010;24(8):501–13.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nemoto T, et al. HIV-related risk behaviors among kathoey (male-to-female transgender) sex workers in Bangkok. Thailand. AIDS Care. 2012;24(2):210–9.PubMedGoogle Scholar
  10. 10.
    Operario D, Soma T, Underhill K. Sex work and HIV status among transgender women: systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2008;48(1):97–103.CrossRefPubMedGoogle Scholar
  11. 11.
    Vittinghoff E, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.CrossRefPubMedGoogle Scholar
  12. 12.
    Leon SR, et al. High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in anal and pharyngeal sites among a community-based sample of men who have sex with men and transgender women in Lima, Peru. BMJ Open. 2016;6(1):e008245.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tang EC, et al. The syphilis care cascade: tracking the course of care after screening positive among men and transgender women who have sex with men in Lima, Peru. BMJ Open. 2015;5(9):e008552.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Allan-Blitz LT, et al. High prevalence of extra-genital chlamydial or gonococcal infections among men who have sex with men and transgender women in Lima, Peru. Int J STD AIDS. 2016;28:138–44.CrossRefPubMedGoogle Scholar
  15. 15.
    Castillo R, et al. HIV and sexually transmitted infection incidence and associated risk factors among high-risk MSM and male-to-female transgender women in Lima, Peru. J Acquir Immune Defic Syndr. 2015;69(5):567–75.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Perez-Brumer AG, et al. Anonymous partnerships among MSM and transgender women (TW) recently diagnosed with HIV and other STIs in Lima, Peru: an individual-level and dyad-level analysis. Sex Transm Infect. 2016;92:554–7.CrossRefGoogle Scholar
  17. 17.
    Verre MC, et al. Socialization patterns and their associations with unprotected anal intercourse, HIV, and syphilis among high-risk men who have sex with men and transgender women in Peru. AIDS Behav. 2014;18(10):2030–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Cambou MC, et al. The risk of stable partnerships: associations between partnership characteristics and unprotected anal intercourse among men who have sex with men and transgender women recently diagnosed with HIV and/or STI in Lima, Peru. PLoS ONE. 2014;9(7):e102894.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Lee SW, et al. A cross-sectional study of low HIV testing frequency and high-risk behaviour among men who have sex with men and transgender women in Lima. Peru. BMC Public Health. 2015;15:408.CrossRefPubMedGoogle Scholar
  20. 20.
    Logie CH, et al. Adapting the minority stress model: associations between gender non-conformity stigma, HIV-related stigma and depression among men who have sex with men in South India. Soc Sci Med. 2012;74(8):1261–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Bockting WO, et al. Stigma, mental health, and resilience in an online sample of the US transgender population. Am J Public Health. 2013;103(5):943–51.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Pollock L, et al. ‘You should build yourself up as a whole product’: transgender female identity in Lima, Peru. Glob Public Health. 2016;11(7–8):981–93.CrossRefPubMedGoogle Scholar
  23. 23.
    Gamarel KE, et al. Gender minority stress, mental health, and relationship quality: a dyadic investigation of transgender women and their cisgender male partners. J Fam Psychol. 2014;28(4):437–47.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Clements-Nolle K, et al. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health. 2001;91(6):915–21.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Clements-Nolle K, Marx R, Katz M. Attempted suicide among transgender persons: the influence of gender-based discrimination and victimization. J Homosex. 2006;51(3):53–69.CrossRefPubMedGoogle Scholar
  26. 26.
    Hotton AL, et al. Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women. AIDS Educ Prev. 2013;25(1):62–71.CrossRefPubMedGoogle Scholar
  27. 27.
    Brennan J, et al. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health. 2012;102(9):1751–7.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Herbst JH, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1–17.CrossRefPubMedGoogle Scholar
  29. 29.
    Operario D, Nemoto T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S91–3.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Chow JY, et al. Peru’s HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention. Int J STD AIDS. 2016;27(12):1039–48.CrossRefPubMedGoogle Scholar
  31. 31.
    Gardner EM, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    World Health Organization (WHO). Antiretroviral Treatment as Prevention (TASP) of HIV and TB, in HIV/AIDS Programme. Geneva: WHO; 2012.Google Scholar
  33. 33.
    Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S235–42.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sevelius JM, et al. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Sevelius JM, et al. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009;21(2):113–27.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Reisner S, et al. Discrimination and health in Massachusetts: a statewide survey of transgender and gender nonconforming adults. Boston: The Fenway Institute, Fenway Health; 2014.Google Scholar
  37. 37.
    Coleman E, et al. World professional association for transgender health, standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. Int J Transgenderism. 2011;13:165–232.CrossRefGoogle Scholar
  38. 38.
    Socias ME, et al. Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health. 2014;13(1):81.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Rotondi NK, et al. Nonprescribed hormone use and self-performed surgeries: “do-it-yourself” transitions in transgender communities in Ontario, Canada. Am J Public Health. 2013;103(10):1830–6.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    de Haan G, et al. Non-prescribed hormone use and barriers to care for transgender women in San Francisco. LGBT Health. 2015;2(4):313–23.CrossRefPubMedGoogle Scholar
  41. 41.
    Gooren LJ, et al. Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand. Cult Health Sex. 2015;17(1):92–103.CrossRefPubMedGoogle Scholar
  42. 42.
    Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27(4):493–505.CrossRefPubMedGoogle Scholar
  43. 43.
    Deutsch MB, Feldman JL. Updated recommendations from the world professional association for transgender health standards of care. Am Fam Physician. 2013;87(2):89–93.PubMedGoogle Scholar
  44. 44.
    Palys T. Purposive sampling. The sage encyclopedia of qualitative research methods. Thousand Oaks, CA: SAGE Publications; 2008. p. 698–9.Google Scholar
  45. 45.
    Bastos FI, et al. AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int J Epidemiol. 2008;37(4):729–37.CrossRefPubMedGoogle Scholar
  46. 46.
    Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320(7227):114–6.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Borkan J. Immersion/crystallization. In: Crabtree BFM, Miller WL, editors. Doing qualitative research. 2nd ed. Thousand Oaks: Sage Publications; 1999. p. 179–94.Google Scholar
  48. 48.
    Coffey AJ, Atkinson P. Making sense of qualitative data: complementary research strategies. Thousand Oaks: Sage Publications; 1996.Google Scholar
  49. 49.
    Bockting WO, Robinson BE, Rosser BR. Transgender HIV prevention: a qualitative needs assessment. AIDS Care. 1998;10(4):505–25.CrossRefPubMedGoogle Scholar
  50. 50.
    Newfield E, et al. Female-to-male transgender quality of life. Qual Life Res. 2006;15(9):1447–57.CrossRefPubMedGoogle Scholar
  51. 51.
    Sanchez NF, Sanchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009;99(4):713–9.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Melendez RM, Pinto RM. HIV prevention and primary care for transgender women in a community-based clinic. J Assoc Nurses AIDS Care. 2009;20(5):387–97.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Lurie S. Identifying training needs of health-care providers related to treatment and care of transgendered patients: a qualitative needs assessment conducted in New England. Int J Transgenderism. 2005;8(2–3):93–112.CrossRefGoogle Scholar
  54. 54.
    Bradford JB, Coleman S, Cunningham W. HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21(Suppl 1):S49–58.PubMedGoogle Scholar
  55. 55.
    Remien RH, et al. Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S16–24.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Open Society Foundations (OSF), Transforming health: international rights-based advocacy for trans health. 2013, Open Society Foundations Public Health Program Washington, DC.Google Scholar
  57. 57.
    Reisner S, et al. Transgender community voices: a participatory population perspective. Lancet. 2016;388(10042):327–30.CrossRefPubMedGoogle Scholar
  58. 58.
    Bradford J, et al. Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103(10):1820–9.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Poteat T, German D, Kerrigan D. Managing uncertainty: a grounded theory of stigma in transgender health care encounters. Soc Sci Med. 2013;84:22–9.CrossRefPubMedGoogle Scholar
  60. 60.
    White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Salazar X, et al. Gender, masculinities and HIV/AIDS: perspectives from Peru. In: Boesten J, Poku NK, editors. Gender and HIV/AIDS: critical perspectives from the developing world. Farnham: Ashgate Publishing Surrey; 2009. p. 47–66.Google Scholar
  62. 62.
    Steward WT, et al. HIV-related stigma: adapting a theoretical framework for use in India. Soc Sci Med. 2008;67(8):1225–35.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Sari L. Reisner
    • 1
    • 2
    • 3
  • Amaya G. Perez-Brumer
    • 4
  • Sarah A. McLean
    • 1
  • Javier R. Lama
    • 5
    • 6
  • Alfonso Silva-Santisteban
    • 7
  • Leyla Huerta
    • 8
  • Jorge Sanchez
    • 6
    • 7
  • Jesse L. Clark
    • 9
  • Matthew J. Mimiaga
    • 1
    • 3
    • 10
  • Kenneth H. Mayer
    • 1
    • 11
    • 12
  1. 1.The Fenway InstituteFenway HealthBostonUSA
  2. 2.Division of General PediatricsBoston Children’s Hospital and Harvard Medical SchoolBostonUSA
  3. 3.Department of EpidemiologyHarvard T.H. Chan School of Public HealthBostonUSA
  4. 4.Department of Sociomedical SciencesColumbia University Mailman School of Public HealthNew York CityUSA
  5. 5.Asociación Civil Impacta Salud y EducaciónLimaPeru
  6. 6.Department of Global HealthUniversity of WashingtonSeattleUSA
  7. 7.Universidad Peruana Cayetano HerediaLimaPeru
  8. 8.EpicentroLimaPeru
  9. 9.Department of Medicine, Division of Infectious DiseasesUniversity of California Los AngelesLos AngelesUSA
  10. 10.The Institute for Community Health PromotionBrown University School of Public HealthProvidenceUSA
  11. 11.Department of MedicineHarvard Medical SchoolBostonUSA
  12. 12.Department of Global Health and PopulationHarvard T.H. Chan School of Public HealthBostonUSA

Personalised recommendations